CA2233570C - Detection, prevention et traitement des dermatites digitales papillomateuses - Google Patents

Detection, prevention et traitement des dermatites digitales papillomateuses Download PDF

Info

Publication number
CA2233570C
CA2233570C CA2233570A CA2233570A CA2233570C CA 2233570 C CA2233570 C CA 2233570C CA 2233570 A CA2233570 A CA 2233570A CA 2233570 A CA2233570 A CA 2233570A CA 2233570 C CA2233570 C CA 2233570C
Authority
CA
Canada
Prior art keywords
serpens
ruminant
strain
antigen
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2233570A
Other languages
English (en)
Other versions
CA2233570A1 (fr
Inventor
Dale Wallis
James L. Wallis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2233570A1 publication Critical patent/CA2233570A1/fr
Application granted granted Critical
Publication of CA2233570C publication Critical patent/CA2233570C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

L'invention porte sur l'utilisation du bactéria ou du bactérine de Serpens spp.. Dans des compositions telles que des vaccins, et sur des méthodes de détection, prévention et/ou traitement de dermatites digitales papillomateuses chez les ruminants. Elle permet d'obtenir la souche biologiquement pure du HBL-112 du Serpens spp. et le bactérine de la souche du HBL-112 du Serpens spp..
CA2233570A 1996-08-01 1997-07-31 Detection, prevention et traitement des dermatites digitales papillomateuses Expired - Fee Related CA2233570C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2291596P 1996-08-01 1996-08-01
US60/022,915 1996-08-01
PCT/US1997/012861 WO1998005755A1 (fr) 1996-08-01 1997-07-31 Detection, prevention et traitement des dermatites digitales papillomateuses

Publications (2)

Publication Number Publication Date
CA2233570A1 CA2233570A1 (fr) 1998-02-12
CA2233570C true CA2233570C (fr) 2013-02-19

Family

ID=21812090

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2233570A Expired - Fee Related CA2233570C (fr) 1996-08-01 1997-07-31 Detection, prevention et traitement des dermatites digitales papillomateuses

Country Status (19)

Country Link
US (2) US6162429A (fr)
EP (1) EP0863981B1 (fr)
JP (1) JP2000500027A (fr)
KR (1) KR19990063786A (fr)
CN (1) CN1198185A (fr)
AT (1) ATE443755T1 (fr)
AU (1) AU732317B2 (fr)
BR (1) BR9706543A (fr)
CA (1) CA2233570C (fr)
DE (1) DE69739592D1 (fr)
DK (1) DK0863981T3 (fr)
EA (2) EA002181B1 (fr)
ES (1) ES2336285T3 (fr)
IL (1) IL123922A (fr)
MX (1) MX9802543A (fr)
NZ (1) NZ330050A (fr)
PT (1) PT863981E (fr)
TR (1) TR199800597T1 (fr)
WO (1) WO1998005755A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241992B1 (en) * 1997-09-08 2001-06-05 University Technologies International, Inc. Bovine footrot treatment and prevention
US6667040B2 (en) 1997-09-08 2003-12-23 University Technologies International, Inc. Bovine footrot treatment and prevention
US6287575B1 (en) * 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)
US7097861B1 (en) 2003-02-07 2006-08-29 Jones-Hamilton Co. Method of treating livestock footbath solutions
US8703104B2 (en) * 2007-10-25 2014-04-22 Ecolab Usa Inc Use of metal astringents for the treatment of hairy heel warts
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US10022458B2 (en) 2015-03-05 2018-07-17 Iowa State University Research Foundation, Inc. Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175516A (en) * 1966-04-15 1969-12-23 Science Union & Cie New Phenyl-Aminopropane Derivatives and Preparations Containing them
US3673205A (en) * 1970-03-25 1972-06-27 American Cyanamid Co 6-(m-AMINO AND SUBSTITUTED-AMINO PHENYL)-2,3,5,6-TETRAHYDRO{8 2,1-b{9 THIAZOLES AND METHOD OF USE
US4029763A (en) 1974-08-05 1977-06-14 Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing purified neuraminidase antigen and method of using the same
DE2930706A1 (de) * 1979-07-28 1981-02-05 Medac Klinische Spezialpraep Verfahren zum nachweis von erregerspezifischen antikoerpern
JPS6067474A (ja) * 1983-09-24 1985-04-17 Wakamoto Pharmaceut Co Ltd 新規な１，３，４−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤
US4746613A (en) * 1984-03-02 1988-05-24 Wichmann Robert W Poultry diseases bacterin preparation
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US5630379A (en) * 1996-02-12 1997-05-20 Ssi Corporation Electrically controlled spraying device for cleaning and treating animals
US6287575B1 (en) * 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)

Also Published As

Publication number Publication date
EA002181B1 (ru) 2002-02-28
IL123922A (en) 2005-07-25
EP0863981A4 (fr) 2002-09-18
EP0863981B1 (fr) 2009-09-23
NZ330050A (en) 2000-01-28
DK0863981T3 (da) 2010-02-01
ATE443755T1 (de) 2009-10-15
WO1998005755A1 (fr) 1998-02-12
US6884412B1 (en) 2005-04-26
DE69739592D1 (de) 2009-11-05
AU3809997A (en) 1998-02-25
CA2233570A1 (fr) 1998-02-12
MX9802543A (es) 1998-11-30
EA199800243A1 (ru) 1998-10-29
US6162429A (en) 2000-12-19
TR199800597T1 (xx) 1998-06-22
EA004873B1 (ru) 2004-08-26
KR19990063786A (ko) 1999-07-26
AU732317B2 (en) 2001-04-12
EP0863981A1 (fr) 1998-09-16
ES2336285T3 (es) 2010-04-09
JP2000500027A (ja) 2000-01-11
CN1198185A (zh) 1998-11-04
BR9706543A (pt) 1999-12-28
PT863981E (pt) 2010-01-04
EA200001056A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
Lund et al. Chapter XI laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae
HUE026171T2 (en) A method for treating, preventing and detecting Helicobacter infection
Sabri et al. Efficacy of an outer membrane protein of Pasteurella haemolytica A2, A7 or A9-enriched vaccine against intratracheal challenge exposure in sheep
US10261092B2 (en) Cross-reactive determinants and methods for their identification
Zahran et al. Prevalence, molecular identification and virulence attributes of Salmonella serovars isolated from feces of diarrheic cow and buffalo-calves
CA2233570C (fr) Detection, prevention et traitement des dermatites digitales papillomateuses
US6096323A (en) Vaccine against papillomatous digital dermatitis (PDD)
US6287575B1 (en) Vaccine against papillomatous digital dermatitis (PDD)
Guilloteau et al. Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination
AU2018368580B2 (en) Vaccine compositions for use against digital dermatitis in a mammal
Colby The Humoral Immune Response of Elks (Cervus elaphus nelsoni) and Mice to Vaccination with Brucella abortus Strain RB51
CA3082608C (fr) Compositions vaccinales destinees a etre utilisees contre la dermatite digitee chez un mammifere
US5908630A (en) Swine immunization using live, RTX toxin-secreting organisms
Rose STUDIES ON THE PROTECTIVE POTENTIAL OF OUTER MEMBRANE VESICLES OF BRUCELLA ABORTUS IN MICE
CA2164701A1 (fr) Vaccin purifie de pasteurella haemolytica renfermant du polysaccharide capsulaire et un dipeptide muramylique
Ahmed Molecular Characterization of Pasteurella multocida Vaccine Strains
Mustafa Prevalence of Brucellosis in Cattle, Sheep and Goats of West Darfur State, Sudan
Lyle Comparison of serological and cultural detection of mycobacterial infections in bovine, caprine, ovine, and porcine species
Pei Characterization of Campylobacter jejuni conserved antigens and cell-binding factors for vaccine development

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150731